Medical Penny Stocks: Cytori Therapeutics Receives Japan’s Approval
Medical penny stocks are always intriguing as a company can be one good result away from a stock boom. Cytori Therapeutics (NASDAQ:CYTX) may just be a very good example of this, as the company shared …
Penny Stocks to Watch: Adial Pharmaceuticals Sees Massive Surge in Two Days
We are looking specifically at biotechnology penny stocks today, and one, in particular, seems to be at the tail end of a massive surge.
This penny stock is affordable and popular right now. …
Penny Stocks Under $1 that are Rising: Flex Pharma and NeuroMetrix
Looking at the penny stocks market today, there is clear interest around medical stocks in the biotechnology sector. These stocks are always intriguing because investors never know when the next ‘Eureka!’ breakthrough in medicine may …
GTx Inc Recovers Slightly on the Market Today After a Disastrous September
GTx Inc. (NASDAQ:GTXI) is a biopharmaceutical company that is headquartered in Memphis, Tennessee, and was founded in 1997. The company focuses on discovering and developing medicines in the treatment of stress urinary incontinence (SUI) and …
ProQR Therapeutics Jumps 60% on Favorable Clinical News
Every day, biotech companies are fighting to make the world a better, healthier, and safer place, and if releasing favorable clinical trial news makes shares jump, then that’s a bonus. Today, this happened after results …
Bellerophon Stock Plunges 68% After Committee Terminates INOpulse Study
The biotechnology industry can be a tough one. When trials are a success, a company’s stock flies. However, the opposite can occur when trials get rejected. On Tuesday, the latter happened to Bellerophon Therapeutics. After …
Progenics Pharmaceuticals’ Stock Gets an 8% Boost After FDA Approval
Progenics Pharmaceuticals receives FDA approval for the first drug to treat rare and extremely life-threatening cancers in patients 12 and older. This approval has boosted the company’s stock exponentially on today’s market.
Progenics Pharmaceuticals … Read
Tonix Pharmaceuticals Holding Corp Falls Nearly 70% Today
Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) announced this morning that it would be halting its Phase 3 study of its Tonmya drug, which caused its stock price to drop in dramatic fashion.
After its …
resTORbio Inc’s Positive Phase 2b Trial Results Boost Stock 50%
Shares of resTORbio Inc (NASDAQ:TORC) jumped today after the company announced via press release the results of its phase 2 clinical study. The small biotech company has the drug RTB101, which is used to treat …
FDA Waives BioPharmX Corporation’s Study and Stock Jumps 16%
FDA waives BioPharmX study, in what many would consider a huge break for the company.
FDA Waives BioPharmX Study
The Palo Alto-based specialty pharmaceutical company that develops products for dermatologists announced via press …